EWS-FLI1 induces developmental abnormalities and accelerates sarcoma formation in a transgenic mouse model

Area of Science:

• Oncology
• Developmental Biology
• Genetics

Background:

• Ewing sarcoma is a rare bone cancer characterized by the t(11;22) translocation, leading to the EWS-FLI1 fusion gene.
• Understanding the role of EWS-FLI1 in tumorigenesis and development is crucial for targeted therapies.

Purpose of the Study:

• To investigate the effects of the EWS-FLI1 fusion gene on limb development and tumor formation.
• To determine the role of p53 in EWS-FLI1-induced oncogenesis.

Main Methods:

• Creation of a conditional EWS-FLI1 transgenic mouse model with tissue-specific expression.
• Crossed EWS-FLI1 mice with Prx1-Cre mice for limb bud-specific expression.
• Introduced p53 deletion to assess its impact on tumor development.

Main Results:

• Conditional EWS-FLI1 expression in limb buds caused developmental defects, including limb shortening, muscle atrophy, and skeletal abnormalities.
• EWS-FLI1 alone did not induce tumors but significantly accelerated sarcoma formation in p53-deficient mice (median time reduced from 50 to 21 weeks).
• EWS-FLI1 shifted the tumor phenotype from osteosarcoma (in p53-deleted mice) to poorly differentiated sarcoma.

Conclusions:

• The EWS-FLI1 fusion gene inhibits normal limb development.
• EWS-FLI1 cooperates with p53 loss to accelerate the development of poorly differentiated sarcomas.
• This model provides insights into Ewing sarcoma pathogenesis and potential therapeutic strategies.